Lanean...
MicroRNA-218 enhances gastric cancer cell cisplatin sensitivity by targeting survivin
Gastric cancer (GC) is one of the most prevalent types of cancer worldwide. Cisplatin based chemotherapy is the primary strategy implemented for the treatment of G; however, chemoresistance is a major problem. Previous studies have indicated that microRNAs (miRs) are associated with chemoresistance...
Gorde:
| Argitaratua izan da: | Exp Ther Med |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
D.A. Spandidos
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6257577/ https://ncbi.nlm.nih.gov/pubmed/30542435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6802 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|